Bardy Diagnostics

Info

Contact Jonathan Wu
Title Director of Marketing

Description

Bardy Diagnostics, Inc. is an innovator in digital health and remote patient monitoring, with a focus on providing diagnostically-accurate and patient-friendly cardiac patch and other monitors to the industry. Addressing a long-standing complaint by cardiac electrophysiologists and cardiologists regarding their frequent inability to clearly distinguish the P-wave on ECG strips of existing modalities, the company’s Carnation Ambulatory Monitor (CAM) patch is the industry’s first P-wave centric™ ambulatory cardiac monitor and arrhythmia detection device that is also designed to improve patient compliance for adults and children through its lifestyle-enabling design. Designed to be worn comfortably and discreetly, the female-friendly, hourglass-shaped CAM patch is placed on the center of the chest, directly over the heart for optimum ECG signal collection. The proprietary technology of the CAM patch provides optimal detection and clear recording of the often difficult-to-detect P-wave, the signal of the ECG waveform that is essential for accurate arrhythmia diagnosis.

Company News

Bardy Diagnostics® Announces CE Mark Certification for 14-Day Carnation® Ambulatory Monitor (CAM®) Patch in Europe and Expansion of Home Enrollment Program Amidst COVID-19 Crisis

/
DateMay 26, 2020
"CE marking of the 14-Day CAM patch is a significant corporate milestone and a testament to the quality of the CAM patch and BardyDx's compliance with all applicable European health, safety, performance and environmental requirements," said Ed Vertatschitsch, Chief Operating Officer.
Read More →

Carnation Ambulatory Monitor patch used to detect arrhythmias in COVID-19 patients

/
DateApr 9, 2020
Bardy Diagnostics has announced that its Carnation Ambulatory Monitor (CAM) Patch has been chosen for use in protocols to measure QT Segments in COVID-19 patients who have been prescribed hydroxychloroquine (HCQ). BardyDx’s CAM Patch will be utilised in newly established protocols at hospitals across the Seattle area to monitor cardiac rhythms for COVID-19 patients on HCQ after hospital discharge, as well as for outpatients.
Read More →